Healthy adult participants
Showing 1 - 25 of >10,000
Healthy Participants Trial (Darigabat, Carbamazepine)
Not yet recruiting
- Healthy Participants
- (no location specified)
Apr 11, 2023
Healthy Participants Trial in Tempe (CK-4021586, Placebo for CK-4021586)
Recruiting
- Healthy Participants
- CK-4021586
- Placebo for CK-4021586
-
Tempe, ArizonaCelerion
May 17, 2023
Healthy Trial in Brussels (Sinsunatovir, Bitrex)
Recruiting
- Healthy
- Sinsunatovir
- Bitrex
-
Brussels, Bruxelles-capitale, RĂ©gion DE, BelgiumPfizer Clinical Research Unit - Brussels
Aug 15, 2023
Healthy Volunteers Trial (REGN13335, Matching Placebo)
Not yet recruiting
- Healthy Volunteers
- REGN13335
- Matching Placebo
- (no location specified)
Nov 13, 2023
HIV Trial in Austin (Cabotegravir Formulation F, Cabotegravir Formulation G)
Not yet recruiting
- HIV Infections
- Cabotegravir Formulation F
- Cabotegravir Formulation G
-
Austin, TexasGSK Investigational Site
Sep 4, 2023
Healthy Trial in New Haven (sisunatovir, , moxifloxacin)
Recruiting
- Healthy
- sisunatovir
- +2 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
May 18, 2023
COVID-19 Trial in Joondalup (VYD222, Placebo)
Recruiting
- COVID-19
- VYD222
- Placebo
-
Joondalup, Western Australia, AustraliaLinear Clinical Research
Apr 3, 2023
Healthy Volunteers Trial (BMS-986419 DR Capsule, BMS-986419 IR Tablet)
Not yet recruiting
- Healthy Volunteers
- BMS-986419 DR Capsule
- BMS-986419 IR Tablet
- (no location specified)
Jul 20, 2023
Amyotrophic Lateral Sclerosis (Healthy Volunteers) Trial in Saint Paul (SAR443820, Placebo)
Completed
- Amyotrophic Lateral Sclerosis (Healthy Volunteers)
- SAR443820
- Placebo
-
Saint Paul, MinnesotaPrism Research-Site Number:8400001
Mar 21, 2023
Healthy Participants Trial in Cincinnati (Olezarsen)
Recruiting
- Healthy Participants
-
Cincinnati, OhioMedpace Clinical Pharmacology Unit
Nov 29, 2022
Healthy Participants Trial in Overland Park (Treatment A: Emraclidine 30mg IR tablets (reference), Treatment B: Emraclidine 30mg
Not yet recruiting
- Healthy Participants
- Treatment A: Emraclidine 30mg IR tablets (reference)
- +3 more
-
Overland Park, KansasOverland Park, Kansas
Jun 28, 2023
Healthy Trial (Drug: PF-07817883)
Not yet recruiting
- Healthy
- Drug: PF-07817883
- (no location specified)
Nov 2, 2023